Family · Pharmaceutical analytical standards
Phenoxybenzamine
A non-selective, irreversible alpha-adrenergic blocker patented in the early 1950s; it is used to prepare patients with phaeochromocytoma, a tumour that releases adrenaline and noradrenaline, for surgery. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.
Did you know?It binds to the receptor with a covalent, permanent bond: its effect fades only when the body has made new receptors.
No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
